Aufman Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Aufman Associates's JNJ Position: Q2 2026 in Review
Aufman Associates reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, selling an estimated $8.39K and leaving 3,167 shares worth $804K. The position accounts for 0.32% of the portfolio, ranked #25.
Aufman Associates first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Aufman Associates held 3,167 shares of Johnson & Johnson worth $804K as of Q2 2026.
- Aufman Associates sold 36 Johnson & Johnson shares in Q2 2026, an estimated $8.39K.
- Johnson & Johnson made up 0.32% of Aufman Associates's portfolio in Q2 2026, its #25 holding.
- Aufman Associates first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
- 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Aufman Associates's 13F filing for Q2 2026, filed 12 Aug 2026.